QT
RNAM

Quantbot Technologies’s Avidity Biosciences RNAM Stock Holding History

Quantbot Technologies’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-143
Closed -$4.06K – 2053
2025
Q2 		$4.06K Buy
143
+132
+1,200% +$3.93K ﹤0.01% 1564
2025
Q1 		$325 Sell
11
-9,523
-100% -$297K ﹤0.01% 1410
2024
Q4 		$277K Buy
+9,534
New +$398K 0.01% 979
2024
Q1 		– Sell
-900
Closed -$8.14K – 1881
2023
Q4 		$8.14K Sell
900
-19,700
-96% -$132K ﹤0.01% 1471
2023
Q3 		$131K Buy
20,600
+14,000
+212% +$121K 0.01% 1024
2023
Q2 		$73.2K Buy
+6,600
New +$82.8K ﹤0.01% 1245
2023
Q1 		– Sell
-25,330
Closed -$562K – 1989
2022
Q4 		$562K Buy
25,330
+25,130
+12,565% +$375K 0.04% 534
2022
Q3 		$3K Sell
200
-1,900
-90% -$36.3K ﹤0.01% 1504
2022
Q2 		$30K Buy
2,100
+1,800
+600% +$26.8K ﹤0.01% 1394
2022
Q1 		$5K Buy
+300
New +$5.1K ﹤0.01% 1530
2021
Q4 		– Sell
-300
Closed -$7K – 1853
2021
Q3 		$7K Buy
+300
New +$6.52K ﹤0.01% 1384

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantbot Technologies's RNAM Position: Q3 2025 in Review

Quantbot Technologies sold out of Avidity Biosciences (RNAM) in Q3 2025, closing a stake of 143 shares — an estimated $4.06K sold.

Quantbot Technologies first reported a position in RNAM in Q3 2021 and held it in 11 quarters. The position peaked at $562K in Q4 2022. 272 funds tracked by Wall St. Rank hold RNAM as of Q3 2025.

  • Quantbot Technologies reported no remaining Avidity Biosciences position as of Q3 2025 after selling out during the quarter.
  • Quantbot Technologies sold 143 Avidity Biosciences shares in Q3 2025, an estimated $4.06K.
  • Quantbot Technologies first reported a position in Avidity Biosciences in Q3 2021 and held it in 11 quarters.
  • Quantbot Technologies's Avidity Biosciences position peaked at $562K in Q4 2022.
  • 272 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.